Camp for Children with Narcolepsy Aims to Connect Families
Sponsored by the not-for-profit organization Wake Up Narcolepsy, the camp will take place over a weekend in late September.
Tag: Narcolepsy
All
Latest
All
Latest
More Than Half of People with Narcolepsy Report Missing Second Dose of Twice-Nightly Oxybate Therapy
'The results from the nocturnal adverse event questionnaire illustrate the burden that the second dose places on some patients.'
All
Latest
New Collaboration Aims to Discover Novel Orexin Receptor Agonists for Narcolepsy & Other Sleep Disorders
“While prevailing treatment approaches only address the symptoms associated with narcolepsy type 1, we believe orexin agonists offer a disruptive approach, with the capacity to address the underlying pathology of the disorder."
Narcolepsy Treatment: New Pitolisant Data Published
A new data analysis evaluates time to onset of response to pitolisant for excessive daytime sleepiness and cataplexy in narcolepsy patients.
Read More
7 Narcolepsy Tips for Managing Symptoms
A range of behavioral changes play a significant part in managing narcolepsy, including regulation of caffeine, bedtime routines, and physical activity.
Read More‘Coming to Terms With a Narcolepsy Diagnosis’
A patient describes her experience with discovering that she has narcolepsy.
Read More
Assessing Daytime Sleepiness: AASM Updates Protocols for MSLT & MWT
Standardization of multiple sleep latency tests and maintenance of wakefulness tests will increase the value of results.
Read MoreAvadel Awaits FDA Decision on Once-Nightly Sodium Oxybate for Narcolepsy; Launch Prep Progressing
Avadel Pharmaceuticals plc recently provided a corporate update and announced its financial results for the third quarter ended September 30, 2021.
Read More
Massachusetts Surgeon Fell Asleep in His Car and Missed Emergency Surgery
A spinal surgeon at Boston Medical Center fell asleep in his car when he was scheduled to be in the operating room.
Read MoreThere’s New Hope for People With Idiopathic Hypersomnia
Cleveland Clinic: A new drug may soon be available to treat this rare sleep disorder.
Read More
FDA Gives NLS Pharmaceutics Greenlight for Quilience Narcolepsy Trial
NLS Pharmaceutics announced that the FDA has accepted its investigational new drug application (IND) for Quilience, the company‘s drug candidate for the treatment of narcolepsy.
Read MoreThe Pediatric Narcolepsy Severity Scale is Useful in Clinical Practice
The Pediatric Narcolepsy Severity Scale is a valuable tool to measure narcolepsy symptoms in school-aged children and adolescents, according to study results published in Neurology.
Read More
The Benefits of a Narcolepsy Severity Scale
A self-reported scale improved the management of and provided guidance for narcolepsy type 1 among children and adolescents, according to study findings published in Neurology.
Read MorePatients with Narcolepsy Have Poorer Quality Nighttime Sleep
Patients with narcolepsy, especially narcolepsy type 1 (with cataplexy), have poorer nighttime sleep, according to a new research review.
Read More
Sunosi for Excessive Daytime Sleepiness: 4 Things to Know
Sunosi is a dual-acting dopamine and norepinephrine reuptake inhibitor for the treatment of persistent daytime sleepiness in adults.
Read MoreStudy: How Does Narcolepsy Impact Cognitive Function?
NeurologyAdvisor: A study in the Journal of Clinical Medicine sought to investigate high cognitive functioning in children with narcolepsy, and whether it was a protective factor for school and behavioral difficulties in this population.
Read MoreCOVID Pandemic Changes Sleep of Narcolepsy Patients
The impact of the coronavirus pandemic on people’s daily lives has resulted in altered sleep patterns and an increase in narcolepsy symptoms.
Read MoreDepression Occurs Often in Narcolepsy, But Improves with Treatment
Patients with narcolepsy type 1 frequently experienced depression, depressive symptoms, suicidal thoughts and risk for suicide, especially those who have untreated narcolepsy, according to study findings published in Neurology.
Read More